Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two MORU colleagues and friends have made the Social Media Awards: Malaria Heroes shortlist: Sara Canavati and Cameron Conway.

Sara Canavati with the text: FINALIST - "Sara has dedicated much of her career to promote information on malaria through different social networks. Her Facebook page has inspired many as she keeps her colleagues involved in the latest malaria issues" - Carlos Rivera

An Oxford grad who has worked with SMRU and COMRU, Sara Canavati, is a senior research scientist and infectious diseases epidemiologist who has conducted clinical trials and malaria studies in the Greater Mekong subregion for the last 10 years. She is a finalist in the Regional Malaria Champion Asia Pacific category, and was nominated by the Asia Pacific Malaria Elimination Network (APMEN).

Sara’s primary research interests include malaria elimination, drug efficacy studies; artemisinin and MDR resistance; and the mobile and migrant populations at higher risk of malaria.

An active social media user since 2008 when she did her MSc at the University of Oxford, Sara strongly believes that malaria advocacy is crucial for malaria elimination.

“Scientists can benefit enormously by using social media to promote their own work and stay current in other’s scientists work,” says Sara. “Importantly, social media is a powerful tool to engage non-science audiences in malaria control and elimination. It is a very rewarding activity that all scientists should get more involved in.

Cameron Conway, a former Wellcome Trust-funded Poet in Residence at MORU, was nominated in the People’s Choice for Best Communications category. Cameron is the author of Malaria Poems, which was a 2015 Pulitzer Prize Poetry nominee.

Similar stories

Antimalarial chemoprophylaxis for forest goers could help accelerate malaria elimination in Cambodia

Giving people antimalarials during and after visiting the forest reduced their risk of contracting malaria 6-fold, and could be the missing piece towards eliminating malaria in Asia-Pacific and South America, say Mahidol and Oxford University researchers in a study published in The Lancet Infectious Diseases.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.

INTERBIO-21st study findings could help predict infants at risk of obesity

Fetal abdomen growth and the mother’s blood fat metabolites very early in pregnancy influence a child’s weight, body fat, vision and neurodevelopment at 2 years of age

Using mathematical modelling to fight malaria

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.